211 related articles for article (PubMed ID: 17437716)
21. SHP2 and SOCS3 contribute to Tyr-759-dependent attenuation of interleukin-6 signaling through gp130.
Lehmann U; Schmitz J; Weissenbach M; Sobota RM; Hortner M; Friederichs K; Behrmann I; Tsiaris W; Sasaki A; Schneider-Mergener J; Yoshimura A; Neel BG; Heinrich PC; Schaper F
J Biol Chem; 2003 Jan; 278(1):661-71. PubMed ID: 12403768
[TBL] [Abstract][Full Text] [Related]
22. Biophysical insight into protein-protein interactions in the Interleukin-11/Interleukin-11Rα/glycoprotein 130 signaling complex.
Mori C; Nagatoishi S; Matsunaga R; Kuroda D; Nakakido M; Tsumoto K
Biochem Biophys Res Commun; 2023 Nov; 682():174-179. PubMed ID: 37820452
[TBL] [Abstract][Full Text] [Related]
23. Glycoprotein130 (Gp130)/interleukin-6 (IL-6) signalling in osteoclasts promotes bone formation in periosteal and trabecular bone.
Johnson RW; McGregor NE; Brennan HJ; Crimeen-Irwin B; Poulton IJ; Martin TJ; Sims NA
Bone; 2015 Dec; 81():343-351. PubMed ID: 26255596
[TBL] [Abstract][Full Text] [Related]
24. Interleukin-6 family of cytokines induced activation of different functional sites expressed by gp130 transducing protein.
Chevalier S; Fourcin M; Robledo O; Wijdenes J; Pouplard-Barthelaix A; Gascan H
J Biol Chem; 1996 Jun; 271(25):14764-72. PubMed ID: 8662918
[TBL] [Abstract][Full Text] [Related]
25. A designer hyper interleukin 11 (H11) is a biologically active cytokine.
Dams-Kozlowska H; Gryska K; Kwiatkowska-Borowczyk E; Izycki D; Rose-John S; Mackiewicz A
BMC Biotechnol; 2012 Mar; 12():8. PubMed ID: 22433466
[TBL] [Abstract][Full Text] [Related]
26. The role of proteolysis in interleukin-11 signaling.
Lokau J; Kespohl B; Kirschke S; Garbers C
Biochim Biophys Acta Mol Cell Res; 2022 Jan; 1869(1):119135. PubMed ID: 34624437
[TBL] [Abstract][Full Text] [Related]
27. Synthetic mimetics of the gp130 binding site for viral interleukin-6 as inhibitors of the vIL-6-gp130 interaction.
Sudarman E; Bollati-Fogolín M; Hafner M; Müller W; Scheller J; Rose-John S; Eichler J
Chem Biol Drug Des; 2008 May; 71(5):494-500. PubMed ID: 18373551
[TBL] [Abstract][Full Text] [Related]
28. Signaling conformations of the tall cytokine receptor gp130 when in complex with IL-6 and IL-6 receptor.
Skiniotis G; Boulanger MJ; Garcia KC; Walz T
Nat Struct Mol Biol; 2005 Jun; 12(6):545-51. PubMed ID: 15895091
[TBL] [Abstract][Full Text] [Related]
29. Targeting the glycoprotein 130 receptor subunit to control pain and inflammation.
Jazayeri JA; Upadhyay A; Vernallis AB; Carroll GJ
J Interferon Cytokine Res; 2010 Dec; 30(12):865-73. PubMed ID: 20979530
[TBL] [Abstract][Full Text] [Related]
30. Repurposing the selective estrogen receptor modulator
Thilakasiri P; Huynh J; Poh AR; Tan CW; Nero TL; Tran K; Parslow AC; Afshar-Sterle S; Baloyan D; Hannan NJ; Buchert M; Scott AM; Griffin MD; Hollande F; Parker MW; Putoczki TL; Ernst M; Chand AL
EMBO Mol Med; 2019 Apr; 11(4):. PubMed ID: 30885958
[TBL] [Abstract][Full Text] [Related]
31. In vitro reconstitution of recognition and activation complexes between interleukin-6 and gp130.
Chow D; Ho J; Nguyen Pham TL; Rose-John S; Garcia KC
Biochemistry; 2001 Jun; 40(25):7593-603. PubMed ID: 11412113
[TBL] [Abstract][Full Text] [Related]
32. Signaling mechanisms through gp130: a model of the cytokine system.
Hirano T; Nakajima K; Hibi M
Cytokine Growth Factor Rev; 1997 Dec; 8(4):241-52. PubMed ID: 9620640
[TBL] [Abstract][Full Text] [Related]
33. An interleukin-6 receptor-dependent molecular switch mediates signal transduction of the IL-27 cytokine subunit p28 (IL-30) via a gp130 protein receptor homodimer.
Garbers C; Spudy B; Aparicio-Siegmund S; Waetzig GH; Sommer J; Hölscher C; Rose-John S; Grötzinger J; Lorenzen I; Scheller J
J Biol Chem; 2013 Feb; 288(6):4346-54. PubMed ID: 23209286
[TBL] [Abstract][Full Text] [Related]
34. Functional expression of soluble human interleukin-11 (IL-11) receptor alpha and stoichiometry of in vitro IL-11 receptor complexes with gp130.
Neddermann P; Graziani R; Ciliberto G; Paonessa G
J Biol Chem; 1996 Nov; 271(48):30986-91. PubMed ID: 8940087
[TBL] [Abstract][Full Text] [Related]
35. Characteristic localization of gp130 (the signal-transducing receptor component used in common for IL-6/IL-11/CNTF/LIF/OSM) in the rat brain.
Watanabe D; Yoshimura R; Khalil M; Yoshida K; Kishimoto T; Taga T; Kiyama H
Eur J Neurosci; 1996 Aug; 8(8):1630-40. PubMed ID: 8921254
[TBL] [Abstract][Full Text] [Related]
36. Identification of three distinct receptor binding sites of murine interleukin-11.
Barton VA; Hudson KR; Heath JK
J Biol Chem; 1999 Feb; 274(9):5755-61. PubMed ID: 10026196
[TBL] [Abstract][Full Text] [Related]
37. Structural biology of shared cytokine receptors.
Wang X; Lupardus P; Laporte SL; Garcia KC
Annu Rev Immunol; 2009; 27():29-60. PubMed ID: 18817510
[TBL] [Abstract][Full Text] [Related]
38. The SNP rs4252548 (R112H) which is associated with reduced human height compromises the stability of IL-11.
Lokau J; Göttert S; Arnold P; Düsterhöft S; Massa López D; Grötzinger J; Garbers C
Biochim Biophys Acta Mol Cell Res; 2018 Mar; 1865(3):496-506. PubMed ID: 29237553
[TBL] [Abstract][Full Text] [Related]
39. Constitutively active mutant gp130 receptor protein from inflammatory hepatocellular adenoma is inhibited by an anti-gp130 antibody that specifically neutralizes interleukin 11 signaling.
Sommer J; Effenberger T; Volpi E; Waetzig GH; Bernhardt M; Suthaus J; Garbers C; Rose-John S; Floss DM; Scheller J
J Biol Chem; 2012 Apr; 287(17):13743-51. PubMed ID: 22523320
[TBL] [Abstract][Full Text] [Related]
40. Dual signaling role of the protein tyrosine phosphatase SHP-2 in regulating expression of acute-phase plasma proteins by interleukin-6 cytokine receptors in hepatic cells.
Kim H; Baumann H
Mol Cell Biol; 1999 Aug; 19(8):5326-38. PubMed ID: 10409724
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
